Tender Details
Ref No 15191157
Notice Type

Business new

Bidding

Not specified

Short Description

Trastuzumab Deruxtecan Approved To Treat Adults With Her2-Positive Cancer That Has Spread Or Cannot Be Removed By Surgery

Deadline *
Date 16 Apr 2025
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location United Kingdom
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

Onpe To Implement Digital Voting For Peruvians Abroad